Related references
Note: Only part of the references are listed.Risk of Atrial Fibrillation With Use of Oral and Intravenous Bisphosphonates
Abhishek Sharma et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
Fabrizio D'Ascenzo et al.
ATHEROSCLEROSIS (2013)
Risk of Serious Atrial Fibrillation and Stroke With Use of Bisphosphonates Evidence From a Meta-analysis
Abhishek Sharma et al.
CHEST (2013)
Atorvastatin, Etidronate, or Both in Patients at High Risk for Atherosclerotic Aortic Plaques: A Randomized, Controlled Trial
Tetsuya Kawahara et al.
CIRCULATION (2013)
Bisphosphonate Use Is Associated With Reduced Risk of Myocardial Infarction in Patients With Rheumatoid Arthritis
Frederick Wolfe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
J. -H. Kang et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study)
Koji Ikeda et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials
E. Barrett-Connor et al.
OSTEOPOROSIS INTERNATIONAL (2012)
A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke
J. -H. Kang et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Impact of Bisphosphonates on the Risk of Atrial Fibrillation
Patricia A. Howard et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
Effect of Alendronate on Vascular Calcification in CKD Stages 3 and 4: A Pilot Randomized Controlled Trial
Nigel D. Toussaint et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis
Ippei Kanazawa et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Bisphosphonate use in women and the risk of atrial fibrillation: A systematic review and meta-analysis
Rohit Bhuriya et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials
E. M. Lewiecki et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Atrial Fibrillation and Bisphosphonate Therapy
Michael Pazianas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bisphosphonates and risk of atrial fibrillation: a meta-analysis
Seo Young Kim et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
Anselm Mak et al.
BMC MUSCULOSKELETAL DISORDERS (2009)
Bisphosphonates and Atrial Fibrillation Systematic Review and Meta-Analysis
Yoon Kong Loke et al.
DRUG SAFETY (2009)
The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis
Murat Celiloglu et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?
P. Anagnostis et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Decreased bone mineral density is correlated with increased subclinical atherosclerosis in older, but not younger, Mexican American women and men: The San Antonio Family Osteoporosis Study
John R. Shaffer et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Alendronate and atrial fibrillation
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis - The METEOR trial
John R. Crouse et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Michael J. Bradburn et al.
STATISTICS IN MEDICINE (2007)
Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women
LB Tankó et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Osteoporosis and cardiovascular disease - Brittle bones and boned arteries, is there a link?
SI McFarlane et al.
ENDOCRINE (2004)
Mineral exploration: Search for the mechanism of vascular calcification and beyond - The 2003 Jeffrey M. Hoeg Award Lecture
LL Demer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Bone mineral density and the risk of peripheral arterial disease: The Rotterdam Study
M van der Klift et al.
CALCIFIED TISSUE INTERNATIONAL (2002)
Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study
DP Kiel et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
Rate of bone loss is associated with mortality in older women: A prospective study
DM Kado et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
